Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : Á¤º¸¸¶´ç : Á¤Ã¥µ¿Çâ
   
Á¤º¸¸¶´ç
ÀǾàǰ°ü·Ã Çà»ç
¿¬±¸ÀÔÂû°ø°í Á¤Ã¥µ¿Çâ
ÇØ¿ÜÁ¤Ã¥µ¿Çâ
 
 
 
Á¦     ¸ñ ÀÏÂ÷ÀÇ·á ÁßÀç¿¡ °üÇÑ ¸®¾ó¿ùµå Æò°¡ ¾È³»¼­ Àú     ÀÚ ÀÏÂ÷ÀÇ·á ÁßÀç¿¡ °üÇÑ ¸®¾ó¿ùµå Æò°¡ ¾È³»¼­
ºÐ     ¾ß ÀǾàǰÁ¤Ã¥ ÀÚ·áÇüÅ ¿¬±¸º¸°í¼­
ÃâÆÇ»ç/±â°ü¸í Çѱ¹º¸°ÇÀǷῬ±¸¿ø ¹ßÇà³âµµ 2018
±¸     ºÐ
÷ºÎÆÄÀÏ  NECA_201811_ÀÏÂ÷ÀÇ·áÁßÀç¿¡°üÇÑ ¸®¾ó¿ùµåÆò°¡.. (1.1MB, ´Ù¿î·Îµå:6ȸ)
 ºä¾î¼³Ä¡Çϱâ
³»   ¿ë https://www.neca.re.kr/lay1/bbs/S1T11C102/F/39/view.do?article_seq=8067&cpage=1&rows=10&condition=&keyword=&show=&cat=

Áö³­ ¸î ³â°£ °æÇèÀ» ¹ÙÅÁÀ¸·Î ÀÏÂ÷ÀÇ·á ÇöÀå¿¡¼­ ¼öÁýµÇ°í ÃàÀûµÈ µ¥ÀÌÅ͸¦ Ȱ¿ëÇÑ º¸°ÇÀÇ·á Á¤Ã¥ÀÇ ±Ù°Å»ý¼º¿¡ °ü½ÉÀ» °¡Áö°í °è½Ç ÇöÀåÀÇ ÀÇ·á °ü°èÀÚ, ¿¬±¸ÀÚ, Á¤Ã¥°¡ ºÐµé²² ¹Ì±¹ÀÇ °æÇèÀ» º¸´Ù ¼Õ½±°Ô Á¢ÇÒ ¼ö ÀÖµµ·Ï °øÀ¯ÇϰíÀÚ ¹ß°£ÇÑ °¡À̵å¶óÀÎÀÔ´Ï´Ù.

¹øÈ£ ÷ºÎ Á¦¸ñ ÀúÀÚ¸í ÃâÆÇ»ç Á¶È¸
134 ÀÏÂ÷ÀÇ·á ÁßÀç¿¡ °üÇÑ ¸®¾ó¿ùµå Æò°¡ ¾È³»¼­ ÀÏÂ÷ÀÇ·á ÁßÀç¿¡ °üÇÑ ¸®¾ó¿ùµå Æò°¡ ¾È³»¼­ Çѱ¹º¸°ÇÀǷῬ±¸¿ø 1484
133 941
132 2019 ½ÄǰÀǾàǰ¾ÈÀüÆò°¡¿ø-¹Ì±¹¾àÀüÀ§¿øÈ¸(USP) °øµ¿½ÉÆ÷Áö¿ò ¹ßÇ¥ÀÚ·á ½ÄǰÀǾàǰ¾ÈÀüÆò°¡¿ø 1348
131 2019 º¸°Çº¹ÁöºÎ R&D »ç¾÷¿¹»êÅõÀÚ¹æÇâ Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø R&D±âȹ´Ü À̰ü¿ë ±Ç¿À¿¬ Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø 1171
130 º¸°ÇÀÇ·á R&D Åë°è R&D ÁøÈﺻºÎ R&D±âȹ´Ü Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø 1154
129 2012 º¸°Çº¹ÁöÅë°è¿¬º¸ º¸°Çº¹ÁöºÎ º¸°Çº¹ÁöºÎ 6084
128 ½ÉÆò¿ø DRG±¹Á¦½ÉÆ÷Áö¾ö(5.21) ÀÚ·á ½ÉÆò¿ø ½ÉÆò¿ø 5844
127 OECD Çѱ¹ÀÇ·áÀÇ Áú °ËÅä ÃÖÁ¾º¸°í¼­ OECD ÇÁ·ÎÁ§Æ® Áö¿ø´Ü °Ç°­º¸Çè½É»çÆò°¡¿ø 5953
126 »óÀå ¹× ÄÚ½º´Ú Á¦¾à 46»çÀÇ 2011³â °æ¿µ½ÇÀû ¾à»ç½Å¹® ¾à»ç½Å¹® 5025
125 °¢±¹ÀÇ ÀǾàǰ Çã°¡Á¤º¸ °Ë»ö Database ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò 17137

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  ´ÙÀ½ 10ÆäÀÌÁö
 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»